Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
80.15
-1.00 (-1.23%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $5.31 billion as of October 23, 2026. It is the 3,443rd most valuable company in the world and the 1,113th biggest in the United States. Its market cap has increased by 311.55% in one year.
Market Cap
5.31B
Enterprise Value
4.18B
1-Year Change
311.55%
Global Rank
Country Rank
#1,113 United States
Category
ChartMarket Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $5.31B, an increase of 524.81%. That is a compound annual growth rate of 134.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 5.31B | 261.67% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 5.79B |
| CG Oncology | 5.55B |
| Cogent Biosciences | 5.43B |
| Mirum Pharmaceuticals | 5.40B |
| Kodiak Sciences | 5.38B |
| PTC Therapeutics | 5.26B |
| Scholar Rock Holding | 5.11B |
| Travere Therapeutics | 4.94B |